Prospective evaluation of diffusion-weighted MRI of the bladder as a biomarker for prediction of bladder cancer aggressiveness

Urologic Oncology: Seminars and Original Investigations

Volumn 32, Issue 8, 2014, Pages 1166-1171

  Sevcenco, Sabina ^a   Ponhold, Lothar ^a,b   Heinz Peer, Gertraud ^a,b   Fajkovic, Harun ^a   Haitel, Andrea ^a   Susani, Martin ^a   Shariat, Shahrokh F ^a   Szarvas, Tibor ^a   Baltzer, Pascal A T ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Department of Radiology Hospital Sankt Poelten   (Austria)

Author keywords

Biomarker; Bladder cancer; Diffusion weighted imaging; Muscle invasiveness; Sensitivity and specificity; Staging

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTATIC MELANOMA; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR INVASION; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; URINARY BLADDER NEOPLASMS; VERY ELDERLY;

TUMOR MARKER;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 84925938076     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2014.04.019     Document Type: Article

References (19)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013, 63:11-30.
2. Babjuk M., Burger M., Zigeuner R., et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 2013, 64:639-653.
3. Sylvester R.J., van der Meijden A.P., Oosterlinck W., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006, 49. 466-5 [discussion 75-7].
4. Dighe M.K., Bhargava P., Wright J. Urinary bladder masses: techniques, imaging spectrum, and staging. J Comput Assist Tomogr 2011, 35:411-424.
5. Barentsz J.O., Jager G.J., Witjes J.A., Ruijs J.H. Primary staging of urinary bladder carcinoma: the role of MRI and a comparison with CT. Eur Radiol 1996, 6:129-133.
6. Verma S., Rajesh A., Prasad S.R., et al. Urinary bladder cancer: role of MR imaging. Radiographics 2012, 32:371-387.
7. Tekes A., Kamel I., Imam K., et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. Am J Roentgenol 2005, 184:121-127.
8. Koh D.M., Collins D.J. Diffusion-weighted MRI in the body: applications and challenges in oncology. Am J Roentgenol 2007, 188:1622-1635.
9. Wu L.M., Chen X.X., Xu J.R., et al. Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI. Acad Radiol 2013, 20:939-946.
10. Takeuchi M., Sasaki S., Ito M., et al. Urinary bladder cancer: diffusion-weighted MR imaging-accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009, 251:112-121.
11. Abou-El-Ghar M.E., El-Assmy A., Refaie H.F., El-Diasty T. Bladder cancer: diagnosis with diffusion-weighted MR imaging in patients with gross hematuria. Radiology 2009, 251:415-421.
12. Matsuki M., Inada Y., Tatsugami F., Tanikake M., Narabayashi I., Katsuoka Y. Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur Radiol 2007, 17:201-204.
13. Wang H.J., Pui M.H., Guo Y., Yang D., Pan B.T., Zhou X.H. Diffusion-weighted MRI in bladder carcinoma: the differentiation between tumor recurrence and benign changes after resection. Abdom Imaging 2013.
14. Rosenkrantz A.B., Haghighi M., Horn J., et al. Utility of quantitative MRI metrics for assessment of stage and grade of urothelial carcinoma of the bladder: preliminary results. Am J Roentgenol 2013, 201:1254-1259.
15. Kobayashi S., Koga F., Yoshida S., et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol 2011, 21:2178-2186.
16. Avcu S., Koseoglu M.N., Ceylan K., Bulut M.D., Unal O. The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions. Br J Radiol 2011, 84:875-882.
17. Ebisu T., Tanaka C., Umeda M., Aoki I. Principles and clinical applications of diffusion weighted echo planar MR imaging. Nihon Rinsho 1997, 55:1742-1747.
18. Rosenkrantz A.B., Mussi T.C., Spieler B., Melamed J., Taneja S.S., Huang W.C. High-grade bladder cancer: association of the apparent diffusion coefficient with metastatic disease: preliminary results. J Magn Reson Imaging 2012, 35:1478-1483.
19. Stenzl A., Cowan N.C., De Santis M., et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011, 59:1009-1018.